Austrian Breast & Colorectal Cancer Study Group
- Country
- 🇦🇹Austria
- Ownership
- Private
- Established
- 1984-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.abcsg.com
ABCSG C08-Exercise II: Trial of Endurance Exercise Following Adjuvant Chemotherapy for Colorectal Cancer
- Conditions
- Colorectal Carcinoma
- Interventions
- Other: controlOther: endurance exercise
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 92
- Registration Number
- NCT03822572
- Locations
- 🇦🇹
Med. Univ. Graz, Graz, Styria, Austria
🇦🇹BKH Kufstein, Kufstein, Tyrol, Austria
🇦🇹KH St. Josef Braunau, Braunau Am Inn, Upper Austria, Austria
A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis
- Conditions
- SteatohepatitisColorectal Cancer
- Interventions
- Drug: Metformin/Placebo
- First Posted Date
- 2012-02-01
- Last Posted Date
- 2018-12-19
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 8
- Registration Number
- NCT01523639
- Locations
- 🇦🇹
Hospital BHS Ried, Ried, Upper Austria, Austria
🇦🇹KH St. Josef KH, Vienna, Austria
🇦🇹Medical University Graz, Oncology, Graz, Styria, Austria
Preoperative Combined Induction Chemotherapy With Capecitabine, Oxaliplatin, Bevacizumab and Radiotherapy
- Conditions
- Rectal Cancer
- Interventions
- Drug: preoperative induction chemotherapy in combination with bevacizumab followed by combined radiochemotherapy with capecitabine
- First Posted Date
- 2011-09-14
- Last Posted Date
- 2014-03-07
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 25
- Registration Number
- NCT01434147
- Locations
- 🇦🇹
Paracelsus Medical University Salzburg - Oncology, Salzburg, Austria
🇦🇹Medical University of Vienna, General Hospital, Vienna, Austria
🇦🇹Medical University Graz, Oncology, Graz, Styria, Austria
A Phase II Study of Neoadjuvant Trastuzumab+Docetaxel+NPLD+/-Bevacizumab in Her2-pos. Early Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Drug: Trastuzumab, DocetaxelDrug: Trastuzumab+Docetaxel+NPLDDrug: Trastuzumab+Docetaxel+NPLD+Bevacizumab
- First Posted Date
- 2011-06-06
- Last Posted Date
- 2014-05-13
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 100
- Registration Number
- NCT01367028
- Locations
- 🇦🇹
Gynaegological Medical University Innsbruck, Innsbruck, Tyrol, Austria
🇦🇹Paracelsus Medical University Salzburg-Oncology, Coop. Group, Salzburg, Austria
🇦🇹District Hospital Kufstein, Kufstein, Tyrol, Austria
Physical Activity for Reduction of Recurrence Rate After Adjuvant Chemotherapy for Localised Colorectal Carcinoma
- Conditions
- Colorectal Carcinoma
- Interventions
- Other: Physical exercise
- First Posted Date
- 2010-09-28
- Last Posted Date
- 2022-06-09
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 30
- Registration Number
- NCT01210313
- Locations
- 🇦🇹
Hospital BHB St. Veit/Glan, Surgery, St. Veit a. d. Glan, Carinthia, Austria
🇦🇹Medical University Innsbruck, Internal Medicine, Innsbruck, Tyrol, Austria
🇦🇹District Hospital Kufstein, Kufstein, Tyrol, Austria
Primary Operation in SYnchronous meTastasized InVasivE Breast Cancer
- Conditions
- Circulating Tumor CellsSynchronous Metastasized Breast Cancer
- Interventions
- Procedure: Surgery on DemandProcedure: Surgery
- First Posted Date
- 2009-11-18
- Last Posted Date
- 2024-08-19
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 90
- Registration Number
- NCT01015625
- Locations
- 🇦🇹
Hospital Guessing, Guessing, Burgenland, Austria
🇦🇹Gynaegological Medical University Graz, Graz, Styria, Austria
🇦🇹Medical University Graz, Oncology, Graz, Styria, Austria
Preoperative Combined RadioChemo-Molecular Target Therapy With Capecitabine, Bevacizumab, and Radiotherapy
- Conditions
- Rectal Cancer
- Interventions
- Drug: capecitabine, bevacizumab
- First Posted Date
- 2008-05-05
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 8
- Registration Number
- NCT00671645
- Locations
- 🇦🇹
Hospital BHB St. Veit/Glan, Surgery, St. Veit/Glan, Carinthia, Austria
🇦🇹Hospital BHS Linz, Radiooncology, Linz, Upper Austria, Austria
🇦🇹State Hospital Feldkirch, Radiotherapy, Feldkirch, Vorarlberg, Austria
Randomized Study Comparing CMF and Goserelin + Tamoxifen in Premenopausal Receptor-positive Patients
- Conditions
- Early-stage Breast Cancer
- Interventions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 1099
- Registration Number
- NCT00309478
Randomized Study Comparing Pre- and Postoperative vs. Conventional Adjuvant Treatment in Receptor-negative Patients
- Conditions
- Early Stage Breast Cancer
- Interventions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2020-10-14
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 429
- Registration Number
- NCT00309569
Randomized Study Comparing Tamoxifen vs. Tamoxifen + Aminoglutethimide in Postmenopausal Receptor-positive Patients
- Conditions
- Early-stage Breast Cancer
- Interventions
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2020-10-19
- Lead Sponsor
- Austrian Breast & Colorectal Cancer Study Group
- Target Recruit Count
- 2021
- Registration Number
- NCT00309491